171 related articles for article (PubMed ID: 10561909)
21. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
[TBL] [Abstract][Full Text] [Related]
22. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
Sokol L; Agosti SJ
Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of 10 patients with chronic lymphoid leukemia].
Fukuda T; Makino S; Tamura K; Suzumiya J; Kimura N; Ohshima K; Kikuchi M; Sagawa K
Rinsho Ketsueki; 1992 Aug; 33(8):1017-24. PubMed ID: 1404856
[TBL] [Abstract][Full Text] [Related]
25. Surface and cytoplasmic immunoglobulin expression in B-cell chronic lymphocytic leukemia (CLL).
Lewis RE; Cruse JM; Pierce S; Lam J; Tadros Y
Exp Mol Pathol; 2005 Oct; 79(2):146-50. PubMed ID: 15963979
[TBL] [Abstract][Full Text] [Related]
26. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
[TBL] [Abstract][Full Text] [Related]
27. Immunological features in chronic lymphocytic leukaemia (CLL) of T cell origin.
Semenzato G; Amadori G; Basso G; Cocito MG; Colombatti M; Anglani F; Gasparotto G
J Clin Lab Immunol; 1979 Apr; 2(1):45-50. PubMed ID: 95805
[TBL] [Abstract][Full Text] [Related]
28. [Heterogeneity of surface antigens in chronic B-cell lymphoid leukemia].
Pálóczi K; Benczúr M; Mihalik R; Solti V; Hollán Z
Orv Hetil; 1991 Jan; 132(1):7-8, 11-3. PubMed ID: 1987510
[TBL] [Abstract][Full Text] [Related]
29. Chronic lymphatic leukemias of T and NK cell type.
Kingreen D; Siegert W
Leukemia; 1997 Apr; 11 Suppl 2():S46-9. PubMed ID: 9178839
[TBL] [Abstract][Full Text] [Related]
30. Sézary syndrome coexisting with B-cell chronic lymphocytic leukemia: case report and review of the literature.
Karsai S; Hou JS; Telang G; Kantor GR; Nowell PC; Vonderheid EC
Dermatology; 2008; 216(1):68-75. PubMed ID: 18032903
[TBL] [Abstract][Full Text] [Related]
31. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
32. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
33. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
[TBL] [Abstract][Full Text] [Related]
34. Aberrant phenotypic expression of the T-cell-associated antigen CD8 on B-cell chronic lymphocytic leukemia cells.
Stagno F; Triolo A; Del Fabro V; Berretta S; Parrinello NL; Fargione G; Di Raimondo F
Lab Hematol; 2009; 15(1):1-3. PubMed ID: 19273392
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
[TBL] [Abstract][Full Text] [Related]
36. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
[TBL] [Abstract][Full Text] [Related]
38. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
[TBL] [Abstract][Full Text] [Related]
39. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
[TBL] [Abstract][Full Text] [Related]
40. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
